Local expression of cytokines in idiopathic inflammatory myopathies

Neuropathology and Applied Neurobiology

Volumn 24, Issue 1, 1998, Pages 73-79

  Lepidi, H ^a   Frances, V ^a   Figarella Branger, D ^a   Bartoli, C ^a   Machado Baeta, A ^a   Pellissier, J F ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Inflammatory myopathies; Proinflammatory cytokines; Th1 cytokines; Th1 immune response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DERMATOMYOSITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; MONONUCLEAR CELL; POLYMYOSITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031882366     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00092.x     Document Type: Article

References (41)

1. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193-208
2. Authier FJ, Mhiri C, Chazaud B et al. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes. Neuropathol Appl Neurobiol 1997; 23: 132-40
3. Belec L, Authier FJ. Chauzaud B et al. Interleukin (IL)-1β and IL-β mRNA production in normal and diseased skeltal muscle tissue assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. J Neuropathol Exp Neurol 1997; 56: 651-663
4. Caestecker MP, Bottomley M, Telfer BA et al. Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int 1993; 44: 1298-308
5. Campbell IL, Kay TW, Oxbrow L, Harrison LC. Essential role for interferon-γ and interleukin-6 in autoimune insuline-dependent diabetes in NOD.Wehi mice. J Clin Invest 1991; 87: 739-42
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9
7. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991; 325: 1487-98
8. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37 (S1): S74-S86
9. Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest 1994; 70: 299-306
10. Dinarello CA. Role of interleukin 1 and tumor necrosis factor in systemic responses to infection and inflammation. In Inflammation: Basic Principles and Clinical Correlates, 2nd edn. Eds JI Gallin, IM Goldstein, and R Snyderman. Raven Press, New York, 1992; 211-32
11. Dinarello CA. The biological properties of interleukin 1. Eur Cytokine Network 1994; 5: 517-31
12. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T-cell mediated cytotoxicity in myopathies. Hum Pathol J 1989; 20: 224-31
13. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27: 343-56
14. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209-15
15. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17: 704-21
16. Figarella-Branger D. Pellissier JF, Bianco N, Devictor B, Toga M. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class major histocompatibility complex product. Acta Neuropathol 1990; 79: 528-36
17. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152: 5532-9
18. Hirano T, Akira S, Taja T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 12: 443-9
19. Isenberg DA, Rowe DJ, Shearer M, Novick D, Beverley PC. Localization of IFN and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 1998; 63: 450-8
20. Jordan M, Otterness IG, Ng SB, Gessner A, Röllinghoff M, Beuscher HV. Neutralization of endogenous IL-6 supresses induction of IL-1 receptor antogonist. J Immunol 1995; 154: 4081-90
21. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encepbalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355-64
22. Kissel JT, Mendell JR, Rammohen KW. Microvascular deposition of complement attack complex in dermatomyositis. N Engl J Med 1986; 314: 329-34
23. Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L. Leukaemia inhibitor factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 1996; 19: 1291-301
24. LeGros GG, Ben-Sasson SS, Seder R, Finkelman FD, Paul WE. Generation of interleukin (IL) -4 producing cells in vivo and in vitro: IL-2 and IL-4 required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172: 921-9
25. Lepidi H, Frances V, Figarella-Branger D, Pellissier JF. Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 1996; 22 (Suppl. 1): 112
26. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34-8
27. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain 1989; 112: 727-47
28. Lundberg I, Brengman JM, Engel AG. Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy and non-weak controls. J Neuroimmunol 1995; 63: 9-16
29. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th 1 and Th 2 clones. J Immunol 1992; 148: 2142-7
30. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-5
31. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992; 35: 874-83
32. Mosmann TR, Coffman RL. Th 1- and Th 2-cells: differents of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73
33. Ng SB, Tan YH, Guy GR. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin 1. J Biol Chem 1994; 269: 19021-7
34. Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304
35. Saghizadeh M, Ong JM, Garwey WT, Henry RR, Kern PA. The expression of TNF-α by human muscle. Relationship to insulin resistance. J Clin Invest 1996; 97: 1111-16
36. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91: 8562-6
37. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14
38. Tews DS, Goebel HH. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol 1996; 55: 342-7
39. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-52
40. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717-21
41. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-9